The symptoms: A man went to the dermatology department of a hospital after experiencing an array of symptoms for about three ...

Equip health professionals with resources to diagnose and treat conditions across all skin tones. Make mental health support ...

Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...

As a result, finding a compatible dermatologist and solution to eczema is not just logistically difficult but often ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

Eczema is a common skin condition that causes itchiness, burning and dryness. Dry skin occurs when your skin loses too much ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...